BSA
CVS icon

Braun Stacey Associates’s CVS Health CVS Stock Holding History

Braun Stacey Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-193,744
Closed -$18.5M – 122
2022
Q3 		$18.5M Sell
193,744
-12,863
-6% -$1.27M 1.12% 27
2022
Q2 		$19.1M Sell
206,607
-20,049
-9% -$1.96M 1.09% 26
2022
Q1 		$22.9M Sell
226,656
-23,903
-10% -$2.51M 0.95% 35
2021
Q4 		$25.8M Buy
250,559
+4,060
+2% +$375K 0.94% 40
2021
Q3 		$20.9M Sell
246,499
-8,163
-3% -$684K 0.84% 51
2021
Q2 		$21.2M Buy
254,662
+5,047
+2% +$413K 0.83% 52
2021
Q1 		$18.8M Buy
249,615
+5,885
+2% +$429K 0.79% 59
2020
Q4 		$16.6M Buy
243,730
+6,168
+3% +$401K 0.75% 65
2020
Q3 		$13.9M Sell
237,562
-16,061
-6% -$999K 0.74% 65
2020
Q2 		$16.5M Buy
253,623
+580
+0.2% +$36.5K 0.95% 41
2020
Q1 		$15M Sell
253,043
-8,075
-3% -$539K 1.14% 27
2019
Q4 		$19.4M Buy
+261,118
New +$18.3M 1.08% 22
2017
Q1 		– Sell
-6,265
Closed -$494K – 144
2016
Q4 		$494K Sell
6,265
-131,975
-95% -$10.7M 0.03% 141
2016
Q3 		$12.3M Sell
138,240
-7,681
-5% -$725K 0.78% 71
2016
Q2 		$14M Sell
145,921
-8,642
-6% -$861K 0.9% 60
2016
Q1 		$16M Sell
154,563
-10,378
-6% -$1.01M 1.05% 40
2015
Q4 		$16.1M Sell
164,941
-7,783
-5% -$762K 1.01% 49
2015
Q3 		$16.7M Sell
172,724
-69,815
-29% -$7.34M 1.12% 32
2015
Q2 		$25.4M Buy
242,539
+58,476
+32% +$5.97M 1.08% 11
2015
Q1 		$19M Sell
184,063
-22,437
-11% -$2.27M 1.11% 27
2014
Q4 		$19.9M Sell
206,500
-4,895
-2% -$431K 1.21% 16
2014
Q3 		$16.8M Buy
211,395
+6,263
+3% +$494K 1.04% 41
2014
Q2 		$15.5M Buy
205,132
+108,732
+113% +$8.22M 0.92% 63
2014
Q1 		$7.22M Buy
96,400
+10,495
+12% +$741K 0.42% 95
2013
Q4 		$6.15M Buy
85,905
+14,600
+20% +$938K 0.35% 99
2013
Q3 		$4.05M Sell
71,305
-6,425
-8% -$383K 0.25% 100
2013
Q2 		$4.44M Buy
+77,730
New +$4.5M 0.28% 100

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Braun Stacey Associates's CVS Position: Q4 2022 in Review

Braun Stacey Associates sold out of CVS Health (CVS) in Q4 2022, closing a stake of 193,744 shares — an estimated $18.5M sold.

Braun Stacey Associates first reported a position in CVS in Q2 2013 and held it in 27 quarters. The position peaked at $25.8M in Q4 2021. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • Braun Stacey Associates reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
  • Braun Stacey Associates sold 193,744 CVS Health shares in Q4 2022, an estimated $18.5M.
  • Braun Stacey Associates first reported a position in CVS Health in Q2 2013 and held it in 27 quarters.
  • Braun Stacey Associates's CVS Health position peaked at $25.8M in Q4 2021.
  • 2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on Braun Stacey Associates's 13F filing for Q4 2022, filed 7 Feb 2023.